Summary & Overview
HCPCS J2290: Nafcillin Sodium Injection, 20 mg
HCPCS Level II code J2290 designates administration of nafcillin sodium, 20 mg, a parenteral antibiotic used to treat susceptible bacterial infections. Nationally, accurate coding for drug administration affects clinical documentation, payer adjudication, and aggregate spending on injectable antimicrobials. This code is used across hospital inpatient settings, outpatient infusion centers, emergency departments, and clinic-based injections.
Key payers reviewed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication summarizes payer coverage patterns, common modifiers and billing considerations, and the clinical contexts in which nafcillin is typically administered. Readers will find concise benchmarks for utilization and reimbursement, an overview of relevant policy updates affecting injectable drug billing, and clinical context that explains when parenteral nafcillin is selected over other agents.
The report is intended for billing managers, clinical leaders, and health policy analysts seeking a national perspective on coding practices for parenteral antibiotics. Data not available in the input for specific ICD-10 pairings and associated taxonomies.
Billing Code Overview
HCPCS Level II code J2290 represents an injection of nafcillin sodium, 20 mg. This code is used to report administration of the antibiotic formulation specified in the code descriptor.
Service type: parenteral antibiotic administration
Typical site of service: inpatient hospitals, outpatient infusion centers, emergency departments, and clinics where intravenous or intramuscular antibiotic therapy is provided.
Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult admitted to an inpatient ward or seen in an outpatient infusion clinic for treatment of a confirmed or suspected serious Gram-positive bacterial infection susceptible to nafcillin, such as methicillin-sensitive Staphylococcus aureus (MSSA) bacteremia, complicated skin and soft tissue infection, osteomyelitis, or septic arthritis. The prescribing physician — commonly an infectious disease specialist, hospitalist, or emergency medicine physician — orders intravenous nafcillin. Pharmacy prepares the J2290 product as the billed nafcillin sodium 20 mg injection. Nursing documents administration of the dose, monitors the patient for infusion-related adverse reactions (eg, allergic reaction, phlebitis), and records vital signs. For inpatients, therapy is typically given via peripheral IV or central line multiple times daily depending on dose; outpatient parenteral antibiotic therapy (OPAT) programs may coordinate home infusion with visiting nurses or infusion centers. Relevant steps in the workflow include medication order entry, allergy verification, preparation by pharmacy, administration by nursing, monitoring, documentation of dose and site, and billing of J2290 with appropriate modifiers reflecting service circumstances.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier; standard billing indicator |